UK Biotech Defies Pandemic, On Course For Record Fundraising Year

But IPO Number Still Low

 
• By Andrew McConaghie

The UK’s biotech sector sees investor interest surge during the pandemic, though IPO levels are still disappointing compared with recent years.

LONDON- DECEMBER, 2017: White City Place, a business district comprising of office buildings and food outlets formerly known as the BBC Media Centre, close to Shepherds Bush
West London's White City Place is one of the UK's newest biotech clusters, home to mid-stage Autolous Therapeutics and early stage biotechs such as GammaDelta.

More from Business

More from Scrip